Results 81 to 90 of about 3,049 (238)

Lipoprotein apheresis efficacy and challenges: single center experience

Hematology, Transfusion and Cell Therapy, 2022
Introduction: Lipoprotein apheresis (LA) is an extracorporeal therapy which removes apolipoprotein B-containing particles from the circulation. We evaluated techniques and efficiency of lipoprotein apheresis procedures applied to patients with familial ...
Zehra Narlı Özdemir, Uğur Şahin, Yasin Yıldırım, Cansın Tulunay Kaya, Osman İlhan   +4 more
doaj  

Eight novel LDL receptor gene mutations among patients under LDL apheresis in Dresden and Leipzig Communicated by Mark H. Paalman Online Citation: Human Mutation, Mutation in Brief #392 (2000) Online http://journals.wiley.com/1059-7794/pdf/mutation/392.pdf [PDF]

, 2001
H. Bochmann, J. Geisel, W. Herrmann, T. Purcz, W. Reuter, Ulrich Julius, W. Metzler, S. Bergmann, W. Jaross, S. Gehrisch   +9 more
openalex   +2 more sources

LDL‐aférese no tratamento de hipercolesterolemia familiar: experiência do Hospital Santo António

Revista Portuguesa de Cardiologia, 2015
Resumo: Introdução: A hipercolesterolemia manifestada pelos níveis elevados de colesterol das lipoproteínas de baixa densidade constitui um fator de risco major para o desenvolvimento e progressão da doença aterosclerótica prematura.A adsorção direta de
Isabel Palma, Ana Rita Caldas, Isabel Mangas Palma, José Alexandre Queirós, Anselmo Madureira, José Carlos Oliveira, Paulo Palma, Carlos Correia, Maria Helena Ramos   +8 more
doaj  

Familial hypercholesterolemia: A review

Annals of Pediatric Cardiology, 2014
Familial hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism resulting in elevated serum low-density lipoprotein (LDL) cholesterol levels leading to increased risk for premature cardiovascular diseases (CVDs).
Mithun J Varghese
doaj   +1 more source

Lipoprotein apheresis to treat elevated lipoprotein (a)1

Journal of Lipid Research, 2016
An elevated plasma concentration of lipoprotein (a) [Lp(a)] is an independent risk factor for cardiovascular disease. Life style modification and currently available drugs either fail to effectively lower plasma Lp(a) levels or do not result in clinical ...
Elisa Waldmann, Klaus G. Parhofer
doaj  

Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia[S]

Journal of Lipid Research, 2014
Lipoprotein-apheresis (apheresis) removes LDL-cholesterol in patients with severe dyslipidemia. However, reduction is transient, indicating that the long-term cardiovascular benefits of apheresis may not solely be due to LDL removal. Microparticles (MPs)
Katherine D. Connolly, Gareth R. Willis, Dev B.N. Datta, Elizabeth A. Ellins, Kristin Ladell, David A. Price, Irina A. Guschina, D. Aled Rees, Philip E. James   +8 more
doaj  

Use of Angiotensin (AII) antagonist losartan in patient treated with DSC LDL-apheresis. [PDF]

, 1999
P. Maxia, Stefano Pintus, A. Bianco, Paolo Pintus, A. Sanna   +4 more
openalex   +1 more source

Low-Density Lipoprotein Apheresis in Patients with Acute Kidney Injury Due to Minimal Change Disease Requiring Acute Renal Replacement Therapy

International Journal of Nephrology and Renovascular Disease, 2020
Kohsuke Terada, Koji Mugishima, Sayuri Kawasaki, Fumiaki Itagaki, Takehisa Yamada, Yukinao Sakai Department of Nephrology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanCorrespondence: Yukinao SakaiDepartment of Nephrology, Graduate ...
Terada K, Mugishima K, Kawasaki S, Itagaki F, Yamada T, Sakai Y   +5 more
doaj  

Application of a New Processing Method to Post‐LDL‐apheresis Data [PDF]

, 2002
Franco Corsini, Arrigo F.G. Cicero, Antonia Giannuzzi, A. Gaddi   +3 more
openalex   +1 more source

LDL-apheresis and immunoadsorption: novel methods in the treatment of renal diseases refractory to conventional therapy [PDF]

, 2003
Władysław Sułowicz
openalex   +1 more source